Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furniture Plc Regulatory News (DFS)

Share Price Information for Dfs Furniture Plc (DFS)

Share Price is delayed by 15 minutes
Get Live Data
121.50    0.50 (0.41%)
Bid:
121.50
Ask:
122.00
Spread: 0.50 (0.412%)
Market Cap: £281.29m
DFS Live PriceLast checked at - London Stock Exchange

Intraday Dfs Furniture Plc Share Chart

Pre-stabilisation announcement replacement

9 Mar 2015 12:43

RNS Number : 9130G
UBS Limited
09 March 2015
 



The following amendment has been made to the 'Pre-stabilisation announcement' released on 06 March 2015 at 07:17 under RNS No. 7437G.

 

The offer price has been corrected to 255p.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

Pre-stabilisation announcement

 

 

Not for distribution, directly or indirectly, in or into the United States, Canada, Japan or Australia or any jurisdiction in which such distribution would be unlawful.

 

 

DFS Furniture plc

Stabilisation Notice

 

 

 

UBS Limited (contact: Gareth McCartney; telephone: 0044 20756 82227) hereby gives notice that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6) and MAR 2.3.5 (1) of the Financial Conduct Authority Code of Market Conduct

 

The Securities:

Issuer:

DFS Furniture plc

Offering securities:

Ordinary Shares of 150 pence each

ISIN: GB00BTC0LB89

Offering description:

Initial Public Offering of Ordinary Shares

Offering size:

 80,943,786 Ordinary Shares (excluding Over-allotment Option)

Offer price:

255 pence per Ordinary Share

Stabilisation:

Stabilisation Manager:

UBS Limited

 

Stabilisation period expected to start on:

Approximately 8.00 a.m. (London time) on 6 March 2015

Stabilisation period expected to end no later than:

Close of business on 5 April 2015

Maximum size of over-allotment facility:

12,142,744 Ordinary Shares

Conditions of use of over-allotment facility:

 

May be exercised in whole or in part by the Stabilisation Manager, to the extent permitted by applicable law, at any time during the period commencing with conditional dealings and ending 30 days thereafter

Over-allotment Option:

Terms:

Advent Diamond (Luxembourg) S.à r.l. has granted UBS Limited, in its capacity as Stabilisation Manager and for the account of the underwriters, the option to acquire up to an additional 12,142,744 Ordinary Shares

Exercise period:

30 days from the start of conditional dealings (ending close of business 5 April 2015)

 

 

In connection with the offer of the above securities, the Stabilisation Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager will take any Stabilisation action and any Stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

The offer of the above securities and the distribution of this announcement and other information in connection with the offer of the above securities in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STASSEFEUFISELD
Date   Source Headline
15th Nov 20247:00 amRNSHolding(s) in Company
31st Oct 20244:35 pmRNSHolding(s) in Company
31st Oct 202412:55 pmRNSHolding(s) in Company
28th Oct 202410:09 amRNSHolding(s) in Company
22nd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSAnnual Financial Report 2024 and Notice of AGM
17th Oct 20247:00 amRNSDirectorate Change
10th Oct 20242:34 pmRNSHolding(s) in Company
9th Oct 20243:16 pmRNSHolding(s) in Company
26th Sep 20241:48 pmRNSDirector/PDMR Shareholding
25th Sep 20247:00 amRNSFY24 Preliminary Results
6th Aug 20243:54 pmRNSHolding(s) in Company
12th Jul 20247:00 amRNSDirectorate Change
24th Jun 202411:45 amRNSHolding(s) in Company
12th Jun 20247:00 amRNSPre Close Trading Statement
3rd Jun 20247:00 amRNSTotal Voting Rights
3rd May 20247:00 amRNSTotal Voting Rights
9th Apr 20247:00 amRNSPost 2023 AGM Shareholder Engagement - Update
8th Apr 20247:00 amRNSHolding(s) in Company
19th Mar 20247:00 amRNSInterim Results
19th Jan 20247:00 amRNSTrading Statement
21st Dec 20233:40 pmRNSHolding(s) in Company
1st Dec 20233:36 pmRNSHolding(s) in Company
15th Nov 202312:36 pmRNSHolding(s) in Company
14th Nov 202312:12 pmRNSHolding(s) in Company
10th Nov 20233:26 pmRNSRESULTS OF AGM
7th Nov 20237:00 amRNSHolding(s) in Company
6th Nov 20237:00 amRNSHolding(s) in Company
20th Oct 202312:14 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSAnnual Financial Report
22nd Sep 202310:13 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSHolding(s) in Company
21st Sep 20237:00 amRNSFY23 Preliminary Results
7th Sep 20237:00 amRNS£250M NEW CREDIT FACILITIES SIGNED
17th Jul 20237:00 amRNSTrading Statement
12th Jul 20237:00 amRNSDirector Declaration
9th Jun 20237:00 amRNSDirectorate Change
8th Jun 202310:25 amRNSHolding(s) in Company
3rd May 20239:51 amRNSHolding(s) in Company
21st Apr 20231:54 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim Results
9th Feb 20237:00 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSDirectorate Change
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.